KD-@ fulfilled the non-inferiority criteria for seroconversion rate ( SCR ) and geometric mean titer ( GMT ) of the neutralizing antibody , which were the primary endpoints , at @weeks after the third vaccination ( @ % CI : -@ , @ for the SCR difference and @ , @ for the GMT ratio ) .